Melatonin Attenuates Ferritinophagy/Ferroptosis by Acting on Autophagy in the Liver of an Autistic Mouse Model BTBR T+Itpr3tf/J
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312598 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Giorgia Cominelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Melatonin, Disease Models, Animal, Liver, Autophagy. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Brescia - Italy, FLAMMA S.p.A.- Italy, University of Brescia–Italy.
Abstract (Originalsprache)
Autism spectrum disorders (ASDs) are a pool of neurodevelopment disorders in which social impairment is the main symptom. Presently, there are no definitive medications to cure the symptoms but the therapeutic strategies that are taken ameliorate them. The purpose of this study was to investigate the effects of melatonin (MLT) in treating ASDs using an autistic mouse model BTBR T+Itpr3tf/J (BTBR). We evaluated the hepatic cytoarchitecture and some markers of autophagy, ferritinophagy/ferroptosis, in BTBR mice treated and not-treated with MLT. The hepatic morphology and the autophagy and ferritinophagy/ferroptosis pathways were analyzed by histological, immunohistochemical, and Western blotting techniques. We studied p62 and microtubule-associated protein 1 light chain 3 B (LC3B) for evaluating the autophagy; nuclear receptor co-activator 4 (NCOA4) and long-chain-coenzyme synthase (ACSL4) for monitoring ferritinophagy/ferroptosis. The liver of BTBR mice revealed that the hepatocytes showed many cytoplasmic inclusions recognized as Mallory–Denk bodies (MDBs); the expression and levels of p62 and LC3B were downregulated, whereas ACSL4 and NCOA4 were upregulated, as compared to control animals. MLT administration to BTBR mice ameliorated liver damage and reduced the impairment of autophagy and ferritinophagy/ferroptosis. In conclusion, we observed that MLT alleviates liver damage in BTBR mice by improving the degradation of intracellular MDBs, promoting autophagy, and suppressing ferritinophagy/ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.
- Italian Society for the Study of Orofacial Pain (Società Italiana Studio Dolore Orofacciale-SISDO), 25123 Brescia, Italy.
- Human Microbiome Advanced Project Institute, 20129 Milan, Italy.
- Interdepartmental University Center of Research Adaption and Regeneration of Tissues and Organs-(ARTO), University of Brescia, 25123 Brescia, Italy.
ORCID-Profile: Daniela Pinto, Gaia Favero, Rita Rezzani
Förderung
- University of Brescia - Italy
- FLAMMA S.p.A.- Italy
- University of Brescia–Italy
- FLAMMA S.p.A.–Italy
- Franchini Acciai S.p.A.
Zitieren
APA
Cominelli, G., Lonati, C., Pinto, D., Rinaldi, F., Franco, C., Favero, G., & Rezzani, R. (2024). Melatonin Attenuates Ferritinophagy/Ferroptosis by Acting on Autophagy in the Liver of an Autistic Mouse Model BTBR T+Itpr3tf/J. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312598
Vancouver
Cominelli G, Lonati C, Pinto D, Rinaldi F, Franco C, Favero G, et al. Melatonin Attenuates Ferritinophagy/Ferroptosis by Acting on Autophagy in the Liver of an Autistic Mouse Model BTBR T+Itpr3tf/J. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312598
BibTeX
@article{Cominelli2024,
author = {Cominelli, Giorgia and Lonati, Claudio and Pinto, Daniela and Rinaldi, Fabio and Franco, Caterina and Favero, Gaia and Rezzani, Rita},
title = {Melatonin Attenuates Ferritinophagy/Ferroptosis by Acting on Autophagy in the Liver of an Autistic Mouse Model BTBR T+Itpr3tf/J},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312598}
}
EUVIMED